Trial Profile
A Phase II Study of High-Dose Allovectin-7 in Patients With Advanced Metastatic Melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2012
Price :
$35
*
At a glance
- Drugs Velimogene aliplasmid (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 01 Feb 2012 New trial record